Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2020

May 13, 2020

SELL
$48.35 - $118.68 $4,835 - $11,868
-100 Reduced 9.09%
1,000 $63,000
Q4 2019

Feb 10, 2020

SELL
$57.36 - $124.1 $68,832 - $148,920
-1,200 Reduced 52.17%
1,100 $136,000
Q3 2019

Nov 14, 2019

BUY
$58.69 - $80.46 $70,428 - $96,551
1,200 Added 109.09%
2,300 $153,000
Q2 2019

Aug 14, 2019

SELL
$77.77 - $120.68 $15.8 Million - $24.5 Million
-202,700 Reduced 99.46%
1,100 $88,000
Q1 2019

May 15, 2019

BUY
$91.83 - $120.68 $15 Million - $19.7 Million
163,500 Added 405.71%
203,800 $22.8 Million
Q4 2018

Feb 14, 2019

BUY
$85.79 - $126.46 $17,158 - $25,292
200 Added 0.5%
40,300 $4.06 Million
Q3 2018

Nov 14, 2018

BUY
$88.49 - $127.55 $8,849 - $12,755
100 Added 0.25%
40,100 $5.07 Million
Q2 2018

Aug 14, 2018

BUY
$60.0 - $85.67 $894,000 - $1.28 Million
14,900 Added 59.36%
40,000 $3.36 Million
Q3 2017

Nov 14, 2017

BUY
$57.01 - $118.75 $1.43 Million - $2.98 Million
25,100
25,100 $1.46 Million

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.